It is not officially known that payments from drug and medical device manufacturers to peer reviewers of major medical journals, who are doctors, are NOT transparent.
Pharmaceutical companies want profit and will get it even if they have to promote a product that is not adequately tested with appropriate research for the safety of the people who will be administered it.
See the research and draw your own conclusions.
Copy from this article:
«More than half of the 1962 US physicians included in this study who peer reviewed for the most influential medical journals received industry payments in 2020-2022, with most payments for research. Research payments, especially those provided to an institution, may have different implications than general payments for conflicts of interest. Peer reviewers in this study received $64.18 million in general payments between 2020 and 2022, representing a median general payment of $7614, larger than the median general payment to all physicians in 2018 of $216.5 Additional research and transparency regarding industry payments in the peer review process are needed. Limitations include that it was not known if existing relationships were relevant to the reviewed articles; that reviewers who were not US-based physicians and payments from other entities such as insurance and technology companies were not captured, underestimating industry payments to reviewers of these major journals; and that the findings may not be generalizable to other journals.»
All I can say is that ¨it is just as easy to buy a scientist as it is to buy a politician¨.
Sources of the article: 1, 2, 3, 4, 5
Article that may help:
Funding of scientific articles by industry

Discover more from Diet gun
Subscribe to get the latest posts sent to your email.
Leave a comment